Introduce Anacaulase-bcdb in Skin, Extern, New Tech 7

This code describes the administration of Anacaulase-bcdb, a novel enzymatic debriding agent, directly onto the skin surface. This procedure is performed to remove necrotic tissue from wounds, particularly severe burns, without surgical excision. The external application facilitates the breakdown of eschar while preserving viable tissue.

This code is appropriate for inpatient encounters where Anacaulase-bcdb is applied topically to debride full-thickness or deep partial-thickness burns. It is used when non-surgical enzymatic debridement is chosen as the primary method for eschar removal. This typically occurs in the initial management phase of burn injuries.

• Ensure documentation clearly specifies the use of Anacaulase-bcdb, not other debriding agents.
• Verify the approach is external (topical application) and not an injection or other invasive method.
• This code is for the application of the new technology substance; separate codes may be needed for wound care management or dressing changes.